Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
JAMA (2021) Vol. 326, Iss. 19, pp. 1930-1930
Open Access | Times Cited: 161

Showing 26-50 of 161 citing articles:

Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England
Anna Mensah, Helen Campbell, Julia Stowe, et al.
The Lancet Child & Adolescent Health (2022) Vol. 6, Iss. 6, pp. 384-392
Open Access | Times Cited: 47
Emerging SARS-CoV-2 variants: Why, how, and what's next?
Yu Chen, Qianyun Liu, Li Zhou, et al.
Cell Insight (2022) Vol. 1, Iss. 3, pp. 100029-100029
Open Access | Times Cited: 47
COVID‐19 and plasma cells: Is there long‐lived protection?*
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance
Lirong Cao, Jingzhi Lou, See Yeung Chan, et al.
Nature Medicine (2022) Vol. 28, Iss. 8, pp. 1715-1722
Open Access | Times Cited: 39
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 37
Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection
Denis Mongin, Nils Bürgisser, Gustavo Laurie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
American Journal of Epidemiology (2023) Vol. 193, Iss. 6, pp. 883-897
Open Access | Times Cited: 25
Protection and waning of natural and hybrid COVID-19 immunity
Yair Goldberg, Micha Mandel, Yinon M. Bar-On, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 48
Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
Houssein H. Ayoub, Ghina R. Mumtaz, Shaheen Seedat, et al.
Global Epidemiology (2021) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 40
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents
Pablo García-Valtanen, Christopher M. Hope, Makutiro G. Masavuli, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100651-100651
Open Access | Times Cited: 35
Effectiveness of COVID-19 Vaccines in the General Population of an Italian Region before and during the Omicron Wave
Cecilia Acuti Martellucci, Maria Elena Flacco, Graziella Soldato, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 662-662
Open Access | Times Cited: 32
Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults
Kristen Nishimi, Thomas C. Neylan, Daniel Bertenthal, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e227287-e227287
Open Access | Times Cited: 29
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS
Kate Stevens, Eleni Frangou, Jae Il Shin, et al.
Nephrology Dialysis Transplantation (2022) Vol. 37, Iss. 8, pp. 1400-1410
Open Access | Times Cited: 28
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
Bram Decru, Jan Van Elslande, Sophie Steels, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2
Chrysovalantis Voutouri, C. Corey Hardin, Vivek Naranbhai, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 3
Open Access | Times Cited: 19
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 27
Favorable vaccine-induced SARS-CoV-2–specific T cell response profile in patients undergoing immune-modifying therapies
Martin Qui, Nina Le Bert, Webber Chan, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 26
Long-term Protection Associated With COVID-19 Vaccination and Prior Infection
Mark W. Tenforde, Ruth Link‐Gelles, Manish M. Patel
JAMA (2022) Vol. 328, Iss. 14, pp. 1402-1402
Open Access | Times Cited: 24
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study
Baharak Babouee Flury, Sabine Güsewell, Thomas Egger, et al.
PLoS Medicine (2022) Vol. 19, Iss. 11, pp. e1004125-e1004125
Open Access | Times Cited: 23
Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic
Lei Huang, Francisco Tsz Tsun Lai, Vincent Ka Chun Yan, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 22
Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose
Luca Perico, Marta Todeschini, Federica Casiraghi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences
Ali A. Rabaan, Shamsah H. Al-Ahmed, Hawra Albayat, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 507-507
Open Access | Times Cited: 14
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study
Jennifer H. Ku, Lina S. Sy, Lei Qian, et al.
Vaccine (2023) Vol. 41, Iss. 24, pp. 3636-3646
Open Access | Times Cited: 13
Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai
Bo Zheng, Bronner P. Gonçalves, Pengfei Deng, et al.
eLife (2025) Vol. 13
Open Access
Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021
Michael P. Busch, Susan L. Stramer, Mars Stone, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_2, pp. S254-S263
Open Access | Times Cited: 21

Scroll to top